或者发神韵
发表于 2025-3-30 11:56:50
http://reply.papertrans.cn/47/4645/464469/464469_51.png
minion
发表于 2025-3-30 12:56:22
Acinetobacter: Epidemiology and Control, usually isolated in hospitalized populations: species 2 ., 3 and 13 (.–.).These three species are included in the so-called . complex group, which establish a clear difference between those . species ubiquitous in nature and those found clinically (.–.).
急性
发表于 2025-3-30 20:26:55
http://reply.papertrans.cn/47/4645/464469/464469_53.png
BRAWL
发表于 2025-3-30 21:12:51
http://reply.papertrans.cn/47/4645/464469/464469_54.png
战胜
发表于 2025-3-31 04:15:20
Book 2002s..Innovations in vascular catheter care and prevention of bloodstreaminfections are discussed in this volume as well as the newestinformation in mathematical modeling to understand the epidemiologyand control of infections in intensive care units.
Obverse
发表于 2025-3-31 06:40:09
1568-2501 ecare units..Innovations in vascular catheter care and prevention of bloodstreaminfections are discussed in this volume as well as the newestinformation in mathematical modeling to understand the epidemiologyand control of infections in intensive care units.978-1-4613-5236-5978-1-4615-0781-9Series ISSN 1568-2501
沟通
发表于 2025-3-31 11:48:20
Methicillin-Resistant Staphylococcus Aureus: Is Control Necessary?,for Disease Control and Prevention (CDC) National Nosocomial Infection Surveillance (NNIS) system demonstrate that the prevalence of MRSA infections continues to be higher in ICUs than on non-ICU wards (.). In 1999, MRSA accounted for 52 percent of nosocomial.infections in the ICU patients in NNIS hospitals (.).
过份艳丽
发表于 2025-3-31 14:10:57
http://reply.papertrans.cn/47/4645/464469/464469_58.png
过多
发表于 2025-3-31 18:49:13
http://reply.papertrans.cn/47/4645/464469/464469_59.png
facilitate
发表于 2025-4-1 00:05:50
Modeling of Antibiotic Resistance in the ICU,trol interventions should generate reductions in resistance much more rapidly in hospitals than in communities as a whole; (.) treatment with one antibiotic may be an individual risk factor for acquisition of resistance to another antibiotic, even in the absence of genetically linked resistance mechanisms.